Our work with various institutions, both public and private, has allowed us to produce a range of publications on a regular basis. Below is a sample of our publicly available work, including reports, articles and proceedings, which relates to the areas on which we focus. To obtain a full list or a copy of these publications, please contact us.

The U.S. Chamber International IP Index, Infinite Possibilities, Fourth Edition, February 2016,

Infinite Possibilities IP as a Development Tool: Supplementary Statistical Analysis to the U.S. Chamber International IP Index, February 2016

UP: Unlimited Potential Annex – IP Rights as a Gateway to Building Innovative Economies: Supplementary Statistical Analysis
February 2015
This annex augments the analysis in the Global Intellectual Property Center International IP Index (GIPC Index) concerning the economic benefits of strengthening intellectual property (IP) protection, by comparing the GIPC Index scores with a number of additional variables using correlations (statistical measures of the likelihood of two elements occurring together). In doing so, the annex provides further insight into the role and impact of IP rights on building innovative economies.

Pugatch, M.P., Torstensson, D. & Laufer, M. (2015), The Next Frontier in Ensuring the Quality of Medicines: Maintaining International Quality and Safety Standards in the Manufacturing and Supply of Active Pharmaceutical Ingredients

Pugatch, M.P., Torstensson, D. & Laufer, M. (2015), The Evolution of Pharmacovigilance: Labeling, Packaging and Pharmacopeia Standards

Chu, R. & Pugatch, M.P. (2015), “How to stay one step ahead of an outbreak”, fDiIntelligence, February/March 2015, pp.78-9

UP: Unlimited Potential, GIPC International IP Index, 3rd edition, February 2015

UP: Unlimited Potential Annex – IP Rights as a Gateway to Building Innovative Economies: Supplementary Statistical Analysis, February 2015

Pugatch, M.P., Torstensson, D. & Laufer, M. (2014), Developing a Culture of Pharmacovigilance

Chu, R. (2014), “Staying Ahead: How can robust IP protection help countries prepare for the next Ebola?”, IP Today, December 2014, Vol.21, No.12 (forthcoming) http://www.pugatch-consilium.com/?p=1589

Pugatch, M.P., Chu, R., Laufer, M. & Torstensson, D. (2014), Scaling Up Global Clinical Trial Activity: Key Trends and Policy Lessons, October 2014http://www.pugatch-consilium.com/?p=1589#clinical_trials

Pugatch, M.P, Torestenssen, D, Chu R, (2014) The Creative Industries and the BRICS, September 2014, CISAC, Paris http://www.pugatch-consilium.com/?p=1589#cisac

Pugatch, M.P, Torstensson, D., (2014) Building the Bio-Economy Examining National Biotechnology Industry Development Strategies, May 2014, Pugatch Consilium report, commissioned by BIO http://www.pugatch-consilium.com/?p=1589#Building_The_Bioeconomy

Pugatch, M.P., Torstensson, D., Chu R. (2014) The Value of Cross-Border Data, The Value of Cross-Border Data to Consumers, Companies and Governments, April 2014, Pugatch Consilium report, commissioned by CEO Technology Council http://www.pugatch-consilium.com/?p=1589#cutting_edge

Pugatch, M.P, Disney H, (2014) Innovative Future, Scenario Analysis of Pharmaceutical Innovation and Access to Medicines in Europe, February 2014, a Pugatch Consilium report, commissioned by EFPIA http://www.pugatch-consilium.com/?p=1589#innovative

Pugatch, M.P., Chu, R., Torstensson, D., (2014) Charting the Course – GIPC International IP Index (2nd edition), January 2014, US Chamber of Commerce http://www.pugatch-consilium.com/?p=1589#gipc

Pugatch MP. Stemmet, J. (2013) South Africa’s Intellectual Property Developments – Heading in the Wrong Direction? September 2013 http://www.pugatch-consilium.com/?p=1878

Torstensson, D., Pugatch, M.P (2013) INDIA: International Outlier on IP A Review of India’s Relationship with Intellectual Property Rights and Its Economic Consequences, Global Intellectual Property Center, US Chamber of Commerce, July 2013 http://www.uschamber.com/sites/default/files/reports/India_Outlier_FIN.pdf

Pugatch, M.P., Chu, R., Torstensson, D. (2012), Measuring Momentum GIPC International IP Index (first edition), US Chamber of Commerce http://www.theglobalipcenter.com/measuring-momentum-the-gipc-international-ip-index/

Pugatch, M.P., Chu, R., Torstensson, D. & Dayan, A. (2012), “Does your country deserve investment from biopharma?”, Scientific American worldVIEW 2012, p.85 http://www.saworldview.com/wv/archive/2012/does-your-country-deserve-investment-from-biopharma/

Pugatch, M.P., Torstensson, D. & Chu, R. (2012), Taking stock: How global biotechnology benefits from intellectual property rights, Pugatch Consilium, Commissioned by the Biotechnology Industry Organization http://www.bio.org 

Pugatch, M.P., Chu, R. & Torstensson, D. (2012), Assembling the pharmaceutical R&D puzzle for needs in the developing world: An assessment of new and proposed delinking initiatives aimed at encouraging R&D into neglected and tropical diseases and specific Type II diseases, Pugatch Consilium, Commissioned by the International Federation for Pharmaceutical Manufacturers and Associations

Pugatch, M. P. (2012), Intellectual Property Policy Making in the 21st Century, The WIPO Journal, Iss. 3

Pugatch, M. P. (2012), “Trade-Related Intellectual Property Rights”, in: Woolcock, S. & Heydon, K. (eds), Ashgate Research Companion to International Trade), forthcoming

Pugatch, M. P. (2011), “Overall Economic and Commercial Assessment of Anti-Counterfeiting Trade Agreement (ACTA)”, in: Anti-Counterfeiting Trade Agreement: An Assessment Report, Prepared by the Institute for Globalization and International Regulation, Maastricht University, Commissioned by the Directorate General for External Policies of the Union (European Parliament)

Pugatch, M. P. (2011), “Patent Pools and Collaborative Initiatives: Assessing the Efficacy of Alternative Models to Intellectual Property in Terms of the Ability to Develop New Medicines, Especially for Neglected Diseases – an Empirical Analysis”, European Journal of Risk Regulation, Iss.4/11

Pugatch, M. P. & Chu, R. (2011), “The Strength of Pharmaceutical IPRs vis-à-vis Foreign Direct Investment in Clinical Research: Preliminary Findings”, Journal of Commercial Biotechnology

Pugatch, M. P. (2010), The Role of Intellectual Property Rights in the Transfer of Environmentally Sensitive Technologies (ESTs), Report prepared for the Global Challenges Division, World Intellectual Property Organization (Geneva)

Pugatch, M. P. (2010), “Mitigating Climate Change through the Promotion of Technology Transfer and the Use of Environmentally Sound Technologies (ESTs): The Role of Intellectual Property Rights”, European Journal of Risk Regulation, Iss.4/10, pp.408-414

Pugatch, M.P. (2010), Survey of Licensing Activities in Selected Fields of Environmentally Sound Technologies (ESTs), Submitted to the United Nations Environment Programme (UNEP), the European Patent Office (EPO), and the International Centre for Trade and Sustainable Development (ICTSD)

Pugatch, M.P., Zlotnick, O. & Teubal, M. (2010), “Israel’s High Tech Catch-Up Process: The Role of IPR and Other Policies” in: Odagiri, H., Goto, A., Sunami, A & Nelson, R. (eds), Intellectual Property Rights and Catch-Up: An International Comparative Study (Oxford University Press)

Healy P. & Pugatch, M. P. (2009), Theory versus Practice: Discussing the Governance of Health Technology Assessment Systems, Stockholm Network (London)

Pugatch, M.P. (2009), “The Process of Intellectual Property Policy-Making in the 21st Century – Shifting from a General-Welfare Model to a Multi-Dimensional One”, The European Intellectual Property Review, Vol.6, pp.307-314

Chu, R. & Pugatch, M. P. (2009), Biosimilars or Bio-generics – Discussing the Present, Considering the Future, Stockholm Network (London)

Pugatch, M.P. & Torstensson, D. (2008), The Good, the Bad, and the Ugly – How have Policymakers Dealt with the Growing Complexity of the Intellectual Property Debate and the issue of Online Piracy?, Conference Board of Canada, The International Forum on The Creative Economy, Compendium of Research Papers (Ottawa)

Pugatch, M. P. (2008), If it Ain’t Broke, Don’t Fix It – A Discussion Paper on the Benefits of the Voluntary Market-Driven Approach to Innovation, Stockholm Network (London)

Torstensson, D. & Pugatch, M. P. (2008), Courting Confusion? Where is Canada’s Intellectual Property Policy Heading? Stockholm Network Experts Series on Pharmaceutical IPRs, Paper No.3, Stockholm Network (London)

Argov, R., Davison, H. & Pugatch M. P. (2007), Promoting Technology Transfer in Developing Countries: Lessons from Public-Private Partnerships in the Field of Pharmaceuticals, Stockholm Network Experts’ Series on Pharmaceutical IPRs, Paper No.1, Stockholm Network (London)

Pugatch, M.P. (2006), Creation and Exploitation – Analysis of Sweden’s Intellectual Property Performance, TIMBRO (Stockholm)

Pugatch, M.P. (2006), Damage Assessment of Delays in the Examination and Approval of Patent Applications by the Patent and Trademark Office in Israel, Report Commissioned by the Ministry of Justice, Patent and Trademark Office

Pugatch, M.P. (2006), “Measuring the Strength of National Pharmaceutical Intellectual Property Regimes: Creating a New Pharmaceutical IP Index”, Journal of World Intellectual Property, Vol.9, No.4, pp.373-391

Pugatch, M.P. (2005), Management and Exploitation of Intellectual Property Rights in Government-owned Hospitals in Israel, Prepared for the Gertner Institute (Israel)